ICMR issues advisory on Plasma Therapy

  • IASbaba
  • May 18, 2021
  • 0
UPSC Articles
Print Friendly, PDF & Email

ICMR issues advisory on Plasma Therapy

Part of: GS Prelims and GS-III – Sci & tech 

In news

  • According to an advisory from the Indian Council of Medical Research (ICMR), the use of convalescent plasma has been dropped from the recommended treatment guidelines for COVID-19

Key takeaways

  • PLACID trial conducted last year had found no significant benefit from the use of plasma; it still continued to find a place in the recommended guidelines.
  • According to some experts, the use of such plasma may have caused new mutations to the virus.

Important value additions 


  • Blood plasma is a yellowish liquid component of blood that holds the blood cells of whole blood in suspension. 
  • It is the liquid part of the blood that carries cells and proteins throughout the body. 
  • It makes up about 55% of the body’s total blood volume.
  • This plasma contains viral antibodies that have treatment potential for severe cases of the disease.

Plasma therapy

  • Plasma therapy is a medical procedure that uses the blood of a recovered patient to create antibodies on those infected individuals.
  • It is medically known as convalescent plasma therapy.
  • This treatment uses antibodies found in the blood taken from a recovered Covid-19 patient. 
  • It is then used to treat those with severe SARS-CoV-2 infection to aid recovery.

Related articles 

Plasma Therapy for Covid-19 

For a dedicated peer group, Motivation & Quick updates, Join our official telegram channel – https://t.me/IASbabaOfficialAccount

Subscribe to our YouTube Channel HERE to watch Explainer Videos, Strategy Sessions, Toppers Talks & many more…

Search now.....

Sign Up To Receive Regular Updates